Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 50 years of age or older at the time of screening
- You have advanced chronic kidney disease (stage 4 or 5) that is not being treated with dialysis, meaning your kidneys are working at less than 30% of normal capacity based on a blood test
- Your parathyroid hormone (a hormone that controls calcium levels) is higher than normal, and/or you are already taking certain medications to manage this — such as Alphacalcidol (a form of vitamin D) or Cinacalcet (a medication to lower parathyroid hormone levels)
- You are willing and able to give written consent to take part in the trial
Who may not be able to join:
- You have previously received a kidney transplant
- You are currently taking certain bone-strengthening medications, specifically denosumab or bisphosphonates (such as alendronate or risedronate), as these medications significantly affect how your body manages calcium and bone density
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in percent change in bone mineral density (BMD) between the treatment groups.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.